APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prostaglandin I2

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Prostaglandin I2 Industry Growth and Trends Forecast to 2032

20 December 202594 pages

Choose your research edition.

Industry ResearchProstaglandin I2 Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostaglandin I2 Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Prostaglandin I2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostaglandin I2 Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostaglandin I2 Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Prostaglandin I2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Prostaglandin I2 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Prostaglandin I2 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prostaglandin I2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prostaglandin I2 include Teva, J & J, GSK, Bayer AG, United Therapeutics, Toray and Tide Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Prostaglandin I2 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Prostaglandin I2 market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Prostaglandin I2 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Prostaglandin I2.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Prostaglandin I2 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Prostaglandin I2 Market by Company

Teva

J & J

GSK

Bayer AG

United Therapeutics

Toray

Tide Pharma

Prostaglandin I2 Segment by Type

Epoprostenol Sodium

Iloprost

Treprostinil

Beraprost Sodium

Prostaglandin I2 Segment by Application

For Oral

For Inhalation

For Injection

Prostaglandin I2 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostaglandin I2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostaglandin I2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostaglandin I2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prostaglandin I2 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Prostaglandin I2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Epoprostenol Sodium Table 2. Major Company of Iloprost Table 3. Major Company of Treprostinil Table 4. Major Company of Beraprost Sodium Table 5. Global Prostaglandin I2 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Prostaglandin I2 Sales by Type (2021-2026) & (k units) Table 7. Global Prostaglandin I2 Sales Market Share in Volume by Type (2021-2026) Table 8. Global Prostaglandin I2 Sales by Type (2021-2026) & (US$ Million) Table 9. Global Prostaglandin I2 Sales Market Share in Value by Type (2021-2026) Table 10. Global Prostaglandin I2 Price by Type (2021-2026) & (US$/unit) Table 11. Global Prostaglandin I2 Sales by Type (2027-2032) & (k units) Table 12. Global Prostaglandin I2 Sales Market Share in Volume by Type (2027-2032) Table 13. Global Prostaglandin I2 Sales by Type (2027-2032) & (US$ Million) Table 14. Global Prostaglandin I2 Sales Market Share in Value by Type (2027-2032) Table 15. Global Prostaglandin I2 Price by Type (2027-2032) & (US$/unit) Table 16. North America Prostaglandin I2 Sales by Type (2021-2026) & (k units) Table 17. North America Prostaglandin I2 Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Prostaglandin I2 Sales by Type (2021-2026) & (k units) Table 19. Europe Prostaglandin I2 Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Prostaglandin I2 Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Prostaglandin I2 Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Prostaglandin I2 Sales by Type (2021-2026) & (k units) Table 23. Latin America Prostaglandin I2 Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Prostaglandin I2 Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Prostaglandin I2 Sales by Type (2021-2026) & (US$ Million) Table 26. Prostaglandin I2 Industry Trends Table 27. Prostaglandin I2 Industry Drivers Table 28. Prostaglandin I2 Industry Opportunities and Challenges Table 29. Prostaglandin I2 Industry Restraints Table 30. Global Prostaglandin I2 Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Prostaglandin I2 Revenue Market Share by Company (2021-2026) Table 32. Global Prostaglandin I2 Sales by Company (2021-2026) & (k units) Table 33. Global Prostaglandin I2 Sales Share by Company (2021-2026) Table 34. Global Prostaglandin I2 Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Prostaglandin I2 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Prostaglandin I2 Major Company Production Sites and Headquarters Table 37. Global Prostaglandin I2 Company, Product Type & Application Table 38. Global Prostaglandin I2 Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Prostaglandin I2 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Prostaglandin I2 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Prostaglandin I2 Sales by Region (2021-2026) & (k units) Table 43. Global Prostaglandin I2 Sales Market Share in Volume by Region (2021-2026) Table 44. Global Prostaglandin I2 Sales by Region (2021-2026) & (US$ Million) Table 45. Global Prostaglandin I2 Sales Market Share in Value by Region (2021-2026) Table 46. Global Prostaglandin I2 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Prostaglandin I2 Sales by Region (2027-2032) & (k units) Table 48. Global Prostaglandin I2 Sales Market Share in Volume by Region (2027-2032) Table 49. Global Prostaglandin I2 Sales by Region (2027-2032) & (US$ Million) Table 50. Global Prostaglandin I2 Sales Market Share in Value by Region (2027-2032) Table 51. Global Prostaglandin I2 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Prostaglandin I2 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Prostaglandin I2 Sales by Application (2021-2026) & (k units) Table 54. Global Prostaglandin I2 Sales Market Share in Volume by Application (2021-2026) Table 55. Global Prostaglandin I2 Sales by Application (2021-2026) & (US$ Million) Table 56. Global Prostaglandin I2 Sales Market Share in Value by Application (2021-2026) Table 57. Global Prostaglandin I2 Price by Application (2021-2026) & (US$/unit) Table 58. Global Prostaglandin I2 Sales by Application (2027-2032) & (k units) Table 59. Global Prostaglandin I2 Sales Market Share in Volume by Application (2027-2032) Table 60. Global Prostaglandin I2 Sales by Application (2027-2032) & (US$ Million) Table 61. Global Prostaglandin I2 Sales Market Share in Value by Application (2027-2032) Table 62. Global Prostaglandin I2 Price by Application (2027-2032) & (US$/unit) Table 63. North America Prostaglandin I2 Sales by Application (2021-2026) & (k units) Table 64. North America Prostaglandin I2 Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Prostaglandin I2 Sales by Application (2021-2026) & (k units) Table 66. Europe Prostaglandin I2 Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Prostaglandin I2 Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Prostaglandin I2 Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Prostaglandin I2 Sales by Application (2021-2026) & (k units) Table 70. Latin America Prostaglandin I2 Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Prostaglandin I2 Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Prostaglandin I2 Sales by Application (2021-2026) & (US$ Million) Table 73. Teva Company Information Table 74. Teva Business Overview Table 75. Teva Prostaglandin I2 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Teva Prostaglandin I2 Product Portfolio Table 77. Teva Recent Development Table 78. J & J Company Information Table 79. J & J Business Overview Table 80. J & J Prostaglandin I2 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. J & J Prostaglandin I2 Product Portfolio Table 82. J & J Recent Development Table 83. GSK Company Information Table 84. GSK Business Overview Table 85. GSK Prostaglandin I2 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. GSK Prostaglandin I2 Product Portfolio Table 87. GSK Recent Development Table 88. Bayer AG Company Information Table 89. Bayer AG Business Overview Table 90. Bayer AG Prostaglandin I2 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Bayer AG Prostaglandin I2 Product Portfolio Table 92. Bayer AG Recent Development Table 93. United Therapeutics Company Information Table 94. United Therapeutics Business Overview Table 95. United Therapeutics Prostaglandin I2 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. United Therapeutics Prostaglandin I2 Product Portfolio Table 97. United Therapeutics Recent Development Table 98. Toray Company Information Table 99. Toray Business Overview Table 100. Toray Prostaglandin I2 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Toray Prostaglandin I2 Product Portfolio Table 102. Toray Recent Development Table 103. Tide Pharma Company Information Table 104. Tide Pharma Business Overview Table 105. Tide Pharma Prostaglandin I2 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Tide Pharma Prostaglandin I2 Product Portfolio Table 107. Tide Pharma Recent Development Table 108. North America Prostaglandin I2 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 109. North America Prostaglandin I2 Sales by Country (2021-2026) & (k units) Table 110. North America Prostaglandin I2 Sales Market Share by Country (2021-2026) Table 111. North America Prostaglandin I2 Sales Forecast by Country (2027-2032) & (k units) Table 112. North America Prostaglandin I2 Sales Market Share Forecast by Country (2027-2032) Table 113. North America Prostaglandin I2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Prostaglandin I2 Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Prostaglandin I2 Market Share by Country (2021-2026) Table 116. North America Prostaglandin I2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Prostaglandin I2 Market Share Forecast by Country (2027-2032) Table 118. Europe Prostaglandin I2 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 119. Europe Prostaglandin I2 Sales by Country (2021-2026) & (k units) Table 120. Europe Prostaglandin I2 Sales Market Share by Country (2021-2026) Table 121. Europe Prostaglandin I2 Sales Forecast by Country (2027-2032) & (k units) Table 122. Europe Prostaglandin I2 Sales Market Share Forecast by Country (2027-2032) Table 123. Europe Prostaglandin I2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe Prostaglandin I2 Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe Prostaglandin I2 Market Share by Country (2021-2026) Table 126. Europe Prostaglandin I2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe Prostaglandin I2 Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Prostaglandin I2 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Prostaglandin I2 Sales by Country (2021-2026) & (k units) Table 130. Asia-Pacific Prostaglandin I2 Sales Market Share by Country (2021-2026) Table 131. Asia-Pacific Prostaglandin I2 Sales Forecast by Country (2027-2032) & (k units) Table 132. Asia-Pacific Prostaglandin I2 Sales Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Prostaglandin I2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Prostaglandin I2 Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Prostaglandin I2 Market Share by Country (2021-2026) Table 136. Asia-Pacific Prostaglandin I2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Prostaglandin I2 Market Share Forecast by Country (2027-2032) Table 138. Latin America Prostaglandin I2 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 139. Latin America Prostaglandin I2 Sales by Country (2021-2026) & (k units) Table 140. Latin America Prostaglandin I2 Sales Market Share by Country (2021-2026) Table 141. Latin America Prostaglandin I2 Sales Forecast by Country (2027-2032) & (k units) Table 142. Latin America Prostaglandin I2 Sales Market Share Forecast by Country (2027-2032) Table 143. Latin America Prostaglandin I2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Prostaglandin I2 Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Prostaglandin I2 Market Share by Country (2021-2026) Table 146. Latin America Prostaglandin I2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Prostaglandin I2 Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Prostaglandin I2 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Prostaglandin I2 Sales by Country (2021-2026) & (k units) Table 150. Middle East and Africa Prostaglandin I2 Sales Market Share by Country (2021-2026) Table 151. Middle East and Africa Prostaglandin I2 Sales Forecast by Country (2027-2032) & (k units) Table 152. Middle East and Africa Prostaglandin I2 Sales Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Prostaglandin I2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Prostaglandin I2 Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East and Africa Prostaglandin I2 Market Share by Country (2021-2026) Table 156. Middle East and Africa Prostaglandin I2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East and Africa Prostaglandin I2 Market Share Forecast by Country (2027-2032) Table 158. Key Raw Materials Table 159. Raw Materials Key Suppliers Table 160. Prostaglandin I2 Distributors List Table 161. Prostaglandin I2 Customers List Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Prostaglandin I2 Image Figure 2. Global Prostaglandin I2 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostaglandin I2 Market Size (2021-2032) & (US$ Million) Figure 4. Global Prostaglandin I2 Sales (2021-2032) & (k units) Figure 5. Epoprostenol Sodium Image Figure 6. Global Epoprostenol Sodium Sales YoY Growth (2021-2032) & (k units) Figure 7. Iloprost Image Figure 8. Global Iloprost Sales YoY Growth (2021-2032) & (k units) Figure 9. Treprostinil Image Figure 10. Global Treprostinil Sales YoY Growth (2021-2032) & (k units) Figure 11. Beraprost Sodium Image Figure 12. Global Beraprost Sodium Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Prostaglandin I2 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Prostaglandin I2 Market Share by Type 2025 VS 2032 Figure 15. North America Prostaglandin I2 Sales Market Share in Volume by Type in 2025 Figure 16. North America Prostaglandin I2 Sales Market Share in Value by Type in 2025 Figure 17. Europe Prostaglandin I2 Sales Market Share in Volume by Type in 2025 Figure 18. Europe Prostaglandin I2 Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Prostaglandin I2 Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Prostaglandin I2 Sales Market Share in Value by Type in 2025 Figure 21. Latin America Prostaglandin I2 Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Prostaglandin I2 Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Prostaglandin I2 Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Prostaglandin I2 Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Prostaglandin I2 Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. For Oral Image Figure 28. Global For Oral Sales YoY Growth (2021-2032) & (k units) Figure 29. For Inhalation Image Figure 30. Global For Inhalation Sales YoY Growth (2021-2032) & (k units) Figure 31. For Injection Image Figure 32. Global For Injection Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Prostaglandin I2 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Prostaglandin I2 Market Share by Application 2025 VS 2032 Figure 35. North America Prostaglandin I2 Sales Market Share in Volume by Application in 2025 Figure 36. North America Prostaglandin I2 Sales Market Share in Value by Application in 2025 Figure 37. Europe Prostaglandin I2 Sales Market Share in Volume by Application in 2025 Figure 38. Europe Prostaglandin I2 Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Prostaglandin I2 Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Prostaglandin I2 Sales Market Share in Value by Application in 2025 Figure 41. Latin America Prostaglandin I2 Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Prostaglandin I2 Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Prostaglandin I2 Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Prostaglandin I2 Sales Market Share in Value by Application in 2025 Figure 45. North America Prostaglandin I2 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Prostaglandin I2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Prostaglandin I2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Prostaglandin I2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Prostaglandin I2 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Prostaglandin I2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Prostaglandin I2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Prostaglandin I2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Prostaglandin I2 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Prostaglandin I2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Prostaglandin I2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Prostaglandin I2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Prostaglandin I2 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Prostaglandin I2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Prostaglandin I2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Prostaglandin I2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Prostaglandin I2 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Prostaglandin I2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Prostaglandin I2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Prostaglandin I2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Prostaglandin I2 Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Prostaglandin I2 Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Epoprostenol Sodium
  • Iloprost
  • Treprostinil
  • Beraprost Sodium
Applications
  • For Oral
  • For Inhalation
  • For Injection
Companies covered
  • Teva
  • J & J
  • GSK
  • Bayer AG
  • United Therapeutics
  • Toray
  • Tide Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Prostaglandin I2 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Prostaglandin I2 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Prostaglandin I2 Market by Type
  6. 1.3.1 Epoprostenol Sodium
  7. 1.3.2 Iloprost
  8. 1.3.3 Treprostinil
  9. 1.3.4 Beraprost Sodium
  10. 1.4 Global Prostaglandin I2 Market Size by Type
  11. 1.4.1 Global Prostaglandin I2 Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Prostaglandin I2 Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Prostaglandin I2 Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Prostaglandin I2 Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Prostaglandin I2 Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Prostaglandin I2 Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Prostaglandin I2 Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Prostaglandin I2 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Prostaglandin I2 Industry Trends
  2. 2.2 Prostaglandin I2 Industry Drivers
  3. 2.3 Prostaglandin I2 Industry Opportunities and Challenges
  4. 2.4 Prostaglandin I2 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Prostaglandin I2 Revenue (2021-2026)
  2. 3.2 Global Top Players by Prostaglandin I2 Sales (2021-2026)
  3. 3.3 Global Top Players by Prostaglandin I2 Price (2021-2026)
  4. 3.4 Global Prostaglandin I2 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prostaglandin I2 Major Company Production Sites & Headquarters
  6. 3.6 Global Prostaglandin I2 Company, Product Type & Application
  7. 3.7 Global Prostaglandin I2 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prostaglandin I2 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prostaglandin I2 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prostaglandin I2 Tier 1, Tier 2, and Tier 3
4 Prostaglandin I2 Regional Status and Outlook
  1. 4.1 Global Prostaglandin I2 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Prostaglandin I2 Historic Market Size by Region
  3. 4.2.1 Global Prostaglandin I2 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Prostaglandin I2 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Prostaglandin I2 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Prostaglandin I2 Forecasted Market Size by Region
  7. 4.3.1 Global Prostaglandin I2 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Prostaglandin I2 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Prostaglandin I2 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Prostaglandin I2 by Application
  1. 5.1 Prostaglandin I2 Market by Application
  2. 5.1.1 For Oral
  3. 5.1.2 For Inhalation
  4. 5.1.3 For Injection
  5. 5.2 Global Prostaglandin I2 Market Size by Application
  6. 5.2.1 Global Prostaglandin I2 Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Prostaglandin I2 Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Prostaglandin I2 Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Prostaglandin I2 Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Prostaglandin I2 Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Prostaglandin I2 Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Prostaglandin I2 Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Prostaglandin I2 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Prostaglandin I2 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Prostaglandin I2 Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 J & J
  8. 6.2.1 J & J Company Information
  9. 6.2.2 J & J Business Overview
  10. 6.2.3 J & J Prostaglandin I2 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 J & J Prostaglandin I2 Product Portfolio
  12. 6.2.5 J & J Recent Developments
  13. 6.3 GSK
  14. 6.3.1 GSK Company Information
  15. 6.3.2 GSK Business Overview
  16. 6.3.3 GSK Prostaglandin I2 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GSK Prostaglandin I2 Product Portfolio
  18. 6.3.5 GSK Recent Developments
  19. 6.4 Bayer AG
  20. 6.4.1 Bayer AG Company Information
  21. 6.4.2 Bayer AG Business Overview
  22. 6.4.3 Bayer AG Prostaglandin I2 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bayer AG Prostaglandin I2 Product Portfolio
  24. 6.4.5 Bayer AG Recent Developments
  25. 6.5 United Therapeutics
  26. 6.5.1 United Therapeutics Company Information
  27. 6.5.2 United Therapeutics Business Overview
  28. 6.5.3 United Therapeutics Prostaglandin I2 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 United Therapeutics Prostaglandin I2 Product Portfolio
  30. 6.5.5 United Therapeutics Recent Developments
  31. 6.6 Toray
  32. 6.6.1 Toray Company Information
  33. 6.6.2 Toray Business Overview
  34. 6.6.3 Toray Prostaglandin I2 Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Toray Prostaglandin I2 Product Portfolio
  36. 6.6.5 Toray Recent Developments
  37. 6.7 Tide Pharma
  38. 6.7.1 Tide Pharma Company Information
  39. 6.7.2 Tide Pharma Business Overview
  40. 6.7.3 Tide Pharma Prostaglandin I2 Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Tide Pharma Prostaglandin I2 Product Portfolio
  42. 6.7.5 Tide Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Prostaglandin I2 Sales by Country
  2. 7.1.1 North America Prostaglandin I2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Prostaglandin I2 Sales by Country (2021-2026)
  4. 7.1.3 North America Prostaglandin I2 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Prostaglandin I2 Market Size by Country
  6. 7.2.1 North America Prostaglandin I2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Prostaglandin I2 Market Size by Country (2021-2026)
  8. 7.2.3 North America Prostaglandin I2 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Prostaglandin I2 Sales by Country
  2. 8.1.1 Europe Prostaglandin I2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Prostaglandin I2 Sales by Country (2021-2026)
  4. 8.1.3 Europe Prostaglandin I2 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Prostaglandin I2 Market Size by Country
  6. 8.2.1 Europe Prostaglandin I2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Prostaglandin I2 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Prostaglandin I2 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Prostaglandin I2 Sales by Country
  2. 9.1.1 Asia-Pacific Prostaglandin I2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Prostaglandin I2 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Prostaglandin I2 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Prostaglandin I2 Market Size by Country
  6. 9.2.1 Asia-Pacific Prostaglandin I2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Prostaglandin I2 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Prostaglandin I2 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Prostaglandin I2 Sales by Country
  2. 10.1.1 South America Prostaglandin I2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Prostaglandin I2 Sales by Country (2021-2026)
  4. 10.1.3 South America Prostaglandin I2 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Prostaglandin I2 Market Size by Country
  6. 10.2.1 South America Prostaglandin I2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Prostaglandin I2 Market Size by Country (2021-2026)
  8. 10.2.3 South America Prostaglandin I2 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Prostaglandin I2 Sales by Country
  2. 11.1.1 Middle East and Africa Prostaglandin I2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Prostaglandin I2 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Prostaglandin I2 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Prostaglandin I2 Market Size by Country
  6. 11.2.1 Middle East and Africa Prostaglandin I2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Prostaglandin I2 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Prostaglandin I2 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Prostaglandin I2 Value Chain Analysis
  2. 12.1.1 Prostaglandin I2 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Prostaglandin I2 Production Mode & Process
  7. 12.2 Prostaglandin I2 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Prostaglandin I2 Distributors
  10. 12.2.3 Prostaglandin I2 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst